For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...

研究发现RIPK1介导的血管内皮细胞死亡和炎症对糖尿病的发生和发展起到了重要的作用，可以直接诱导2型糖尿病的发病，促进糖尿病血管并发症的发展以及出现类似糖尿病患者终末期难以治疗的肾损伤，提示了RIPK1是治疗代谢紊乱、糖尿病及终末期血管损伤并发症的重要靶点，为深入研究糖尿病的机理和开发新的治疗手段提供了重要的新思路。

SGLT2 inhibitors were associated with better cardioprotective effects among older adults than younger adults with type 2 diabetes.

The following is a summary of "Cardiac autonomic neuropathy is associated with ectopic fat distribution in autoimmune but not ...

Romosozumab plus alendronate vs alendronate alone was associated with improved lumbar spine BMD in postmenopausal women with T2D.

The following is a summary of "Potential predictive role of Non-HDL to HDL Cholesterol Ratio (NHHR) in MASLD: focus on obese ...

The study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical ...

Micronutrient deficiencies are a growing concern among individuals with type 2 diabetes mellitus (T2D), given their potential impact on metabolic pathways | Immunology ...

According to her, coffee has its negative effects, such as making some individuals tremble, anxious, have difficulties sleeping, and raise their heart rate, even though it lowers cardiovascular risk ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...

2型糖尿病是一种全球性健康问题，其患病率在全球为10.5%。2024年，美国内科医师学会（ACP）发布了一份针对成人2型糖尿病新型药物治疗的临床指南，指南强调在二甲双胍和生活方式调整基础上，优先使用钠-葡萄糖协同转运蛋白-2（SGLT-2）抑制剂或胰高血糖素样肽-1（GLP-1）受体激动剂，以降低全因死亡率、心血管疾病发病率和慢 ...